AIDS Research and Human Retroviruses
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.0 | Q4 | 10.6% | 0.516 | Q3 | 62.0% |
| 2024 | 1.1 | Q4 | 15.3% | 0.554 | Q3 | 65.7% |
| 2023 | 1.5 | Q4 | 17.1% | 0.542 | Q3 | 67.5% |
| 2022 | 1.5 | Q4 | 10.0% | 0.562 | Q3 | 69.9% |
| 2021 | 1.7 | Q4 | 15.8% | 0.640 | Q2 | 74.8% |
| 2020 | — | — | 0.993 | Q2 | 85.2% | |
| 2019 | — | — | 0.988 | Q2 | 85.3% | |
| 2018 | — | — | 1.025 | Q2 | 84.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0889-2229
ISSN
1931-8405
country
UScoverage
1987-2026